Metabolic

Carbohydrate Metabolic Pathways

  • Glycolysis: Glucose breakdown to pyruvate, yielding a bit of ATP and NADH
  • Gluconeogenesis: Making glucose from non-carb sources when glucose is low
  • Glycogenesis: Storing excess glucose as glycogen
  • Glycogenolysis: Breaking down glycogen to release glucose when needed
  • Pentose Phosphate Pathway: Produces NADPH (for building stuff) and ribose-5-phosphate (for DNA/RNA)

Glycolysis

  • Purpose: The central pathway to break down glucose into pyruvate, generating ATP and NADH in the process
  • Location: Cytoplasm of all cells
  • Overview:
    • Investment Phase (Energy Requiring):
      • Glucose is phosphorylated twice, consuming 2 ATP
      • Glucose is converted to fructose-1,6-bisphosphate
    • Payoff Phase (Energy Releasing):
      • Fructose-1,6-bisphosphate is split into two 3-carbon molecules
      • These molecules are converted to pyruvate, generating 4 ATP and 2 NADH
    • Net Yield: 2 ATP, 2 NADH, and 2 pyruvate molecules per glucose molecule
  • Regulation:
    • Key Regulatory Enzymes:
      • Hexokinase/Glucokinase: Inhibited by glucose-6-phosphate (product inhibition). Glucokinase (in the liver) has a higher Km for glucose and is not inhibited by glucose-6-phosphate, allowing the liver to continue taking up glucose even when cellular glucose levels are high
      • Phosphofructokinase-1 (PFK-1): The most important regulatory enzyme
        • Activated by AMP, ADP, and fructose-2,6-bisphosphate
        • Inhibited by ATP and citrate
      • Pyruvate Kinase:
        • Activated by fructose-1,6-bisphosphate (feedforward activation)
        • Inhibited by ATP and alanine
  • Fate of Pyruvate:
    • Aerobic Conditions: Pyruvate is converted to acetyl-CoA, which enters the citric acid cycle
    • Anaerobic Conditions: Pyruvate is converted to lactate (lactic acid fermentation) to regenerate NAD+ for glycolysis to continue

Gluconeogenesis

  • Purpose: To synthesize glucose from non-carbohydrate precursors, primarily in the liver and kidneys
  • Location: Primarily in the liver and kidneys
  • Overview:
    • Reversal of glycolysis with some bypass reactions to overcome irreversible steps
    • Precursors: Pyruvate, lactate, glycerol, and glucogenic amino acids
    • Key Bypass Reactions:
      • Pyruvate to Phosphoenolpyruvate (PEP):
        • Pyruvate carboxylase converts pyruvate to oxaloacetate (in mitochondria)
        • PEP carboxykinase converts oxaloacetate to PEP (in cytoplasm)
      • Fructose-1,6-bisphosphate to Fructose-6-phosphate:
        • Fructose-1,6-bisphosphatase catalyzes this reaction
      • Glucose-6-phosphate to Glucose:
        • Glucose-6-phosphatase catalyzes this reaction (primarily in the liver and kidneys)
    • Energy Cost: Gluconeogenesis is energy-intensive, requiring 6 ATP equivalents per glucose molecule
  • Regulation:
    • Key Regulatory Enzymes:
      • Pyruvate Carboxylase: Activated by acetyl-CoA
      • Fructose-1,6-bisphosphatase:
        • Inhibited by AMP and fructose-2,6-bisphosphate
      • Glucose-6-phosphatase: Regulated by substrate availability (glucose-6-phosphate)
    • Hormonal Regulation:
      • Insulin: Inhibits gluconeogenesis
      • Glucagon: Stimulates gluconeogenesis
      • Cortisol: Stimulates gluconeogenesis

Glycogenesis

  • Purpose: To synthesize glycogen from glucose for storage, primarily in the liver and muscles
  • Location: Cytoplasm of liver and muscle cells
  • Overview:
    • Glucose is converted to glucose-6-phosphate
    • Glucose-6-phosphate is converted to glucose-1-phosphate
    • Glucose-1-phosphate is activated by UTP to form UDP-glucose
    • UDP-glucose is added to a growing glycogen chain by glycogen synthase
    • Branching enzyme creates α-1,6-glycosidic branches
  • Regulation:
    • Key Regulatory Enzyme:
      • Glycogen Synthase:
        • Activated by glucose-6-phosphate and insulin
        • Inhibited by glucagon and epinephrine (via phosphorylation)

Glycogenolysis

  • Purpose: To break down glycogen into glucose for energy, primarily in the liver and muscles
  • Location: Cytoplasm of liver and muscle cells
  • Overview:
    • Glycogen phosphorylase cleaves α-1,4-glycosidic bonds, releasing glucose-1-phosphate
    • Debranching enzyme removes α-1,6-glycosidic branches
    • Glucose-1-phosphate is converted to glucose-6-phosphate
    • In the liver, glucose-6-phosphatase converts glucose-6-phosphate to glucose, which is released into the bloodstream. (Muscle lacks glucose-6-phosphatase, so glucose-6-phosphate enters glycolysis)
  • Regulation:
    • Key Regulatory Enzyme:
      • Glycogen Phosphorylase:
        • Activated by AMP, epinephrine, and glucagon (via phosphorylation)
        • Inhibited by ATP, glucose-6-phosphate, and insulin

Hexose Monophosphate Shunt

  • Nomenclature: Pentose Phosphate Pathway (PPP) or Hexose Monophosphate Shunt (HMP Shunt)
  • Purpose:
    • Production of NADPH: Important for reducing power in anabolic reactions, detoxification of reactive oxygen species, and synthesis of fatty acids and steroids
    • Production of Ribose-5-phosphate: A precursor for nucleotide biosynthesis
  • Location: Cytoplasm of various cells, particularly those involved in lipid synthesis (e.g., liver, adipose tissue, adrenal cortex)
  • Overview:
    • Oxidative Phase:
      • Glucose-6-phosphate is converted to ribulose-5-phosphate, producing NADPH
      • This phase is irreversible
    • Non-Oxidative Phase:
      • Ribulose-5-phosphate is converted to various sugar phosphates (e.g., ribose-5-phosphate, fructose-6-phosphate, glyceraldehyde-3-phosphate)
      • This phase is reversible and allows the pathway to adapt to the cell’s needs
  • Regulation:
    • Key Regulatory Enzyme:
      • Glucose-6-phosphate dehydrogenase (G6PD):
        • Inhibited by NADPH (product inhibition)

Importance and Clinical Relevance

Understanding these pathways is crucial because:

  • Diabetes Mellitus: Disruptions in glucose metabolism are central to the pathophysiology of diabetes
  • Metabolic Disorders: Genetic defects in enzymes of these pathways can lead to various metabolic disorders (e.g., glycogen storage diseases, G6PD deficiency)
  • Nutritional Status: These pathways are highly responsive to dietary intake and hormonal signals, reflecting the body’s adaptation to different nutritional states

Key Terms

  • Glycolysis: The breakdown of glucose to pyruvate, yielding ATP and NADH. It’s the foundation of cellular energy production
  • Gluconeogenesis: The synthesis of glucose from non-carbohydrate precursors. This is vital for maintaining blood glucose levels during fasting or starvation
  • Glycogenesis: The process of converting glucose into glycogen for storage in the liver and muscles
  • Glycogenolysis: The breakdown of glycogen to release glucose, providing a quick source of energy
  • Insulin: A hormone that promotes glucose uptake, glycogenesis, and glycolysis, effectively lowering blood glucose
  • Glucagon: A hormone that stimulates glycogenolysis and gluconeogenesis, raising blood glucose levels
  • ATP (Adenosine Triphosphate): The primary energy currency of the cell. Many of these pathways are geared toward producing or consuming ATP
  • NADPH (Nicotinamide Adenine Dinucleotide Phosphate): A crucial reducing agent in anabolic reactions, like fatty acid and steroid synthesis. It’s a key product of the pentose phosphate pathway